Hamza Alshannaq

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Cardiovascular Disease

Health Insurance

Top Venues

Journal of comparative effectiveness research

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lynch, Stéphane Roze
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France. Journal of comparative effectiveness research 13 (3) (2024)
Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lynch, Stéphane Roze
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France. Journal of comparative effectiveness research 13 (3) (2024)
Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lynch, Stéphane Roze
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France. Journal of comparative effectiveness research 13 (3) (2024)
Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lynch, Stéphane Roze
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France. Journal of comparative effectiveness research 13 (3) (2024)
Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lynch, Stéphane Roze
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France. Journal of comparative effectiveness research (2024)
Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lynch, Stéphane Roze
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France. Journal of comparative effectiveness research 13 (3) (2024)
Hamza Alshannaq, Greg Cogswell, Richard F Pollock, Waqas Ahmed, Greg J Norman, Peter M Lynch, Stephane Roze
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark. Diabetes, obesity & metabolism (2023)
Hamza Alshannaq, John J Isitt, Richard F Pollock, Gregory J Norman, Greg Cogswell, Peter M Lynch, Stéphane Roze
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada. Journal of comparative effectiveness research (2023)